Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Pernus YB"'
Publikováno v:
Praxis. 101:827-838
Wir berichten über einen 16-jährigen Patienten mit einer hämorrhagisch-bullösen Form einer Purpura Schönlein-Henoch, deren Ursache nicht eruiert werden konnte, und die wie erwartet komplikationslos abheilte. Da der Patient wegen einer Akne inver
Autor:
Phuong LK; Monash Children's Hospital, Clayton, Melbourne, Australia; Royal Children's Hospital, Parkville, Victoria, Australia., Bonetto C; Italian Medicines Agency (AIFA), Rome, Italy., Buttery J; Monash Children's Hospital, Clayton, Melbourne, Australia; Murdoch Childrens Research Institute, Parkville, Victoria, Australia; Department of Paediatrics, Monash University, Clayton, Victoria, Australia., Pernus YB; The Brighton Collaboration Foundation, Basel, Switzerland., Chandler R; Uppsala Monitoring Centre, Uppsala, Sweden., Felicetti P; Italian Medicines Agency (AIFA), Rome, Italy., Goldenthal KL; Independent Consultant, Bethesda, MD, USA., Kucuku M; Department of Vaccines Control, National Agency for Medicines and Medical Devices, Tirana, Albania., Monaco G; Pharmacovigilance Regional Centre of Lombardy, Italy., Pahud B; Children's Mercy Hospital, Kansas City, MO, USA., Shulman ST; Ann & Robert H. Lurie Children's Hospital of Chicago, USA., Top KA; Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada., Trotta F; Italian Medicines Agency (AIFA), Rome, Italy., Ulloa-Gutierrez R; Hospital Nacional de Niños 'Dr. Carlos Sáenz Herrera, San José, Costa Rica., Varricchio F; Independent Consultant Vaccinologist, Wakefield, RI, USA., de Ferranti S; Boston Children's Hospital, Boston, USA., Newburger JW; Boston Children's Hospital, Boston, USA., Dahdah N; CHU Sainte-Justine, Montreal, Canada., Singh S; Post Graduate Institute of Medical Education and Research (PGIMER)- Chandigarh, India., Bonhoeffer J; The Brighton Collaboration Foundation, Basel, Switzerland; University of Basel Children's Hospital, Basel, Switzerland. Electronic address: contact@brightoncollaboration.org., Burgner D; Monash Children's Hospital, Clayton, Melbourne, Australia; Murdoch Childrens Research Institute, Parkville, Victoria, Australia; Department of Paediatrics, Monash University, Clayton, Victoria, Australia; Department of Paediatrics, Melbourne University, Parkville, Victoria, Australia.
Publikováno v:
Vaccine [Vaccine] 2017 Mar 27; Vol. 35 (14), pp. 1770-1779. Date of Electronic Publication: 2017 Mar 02.
Autor:
Phuong LK; Monash Children's Hospital, Clayton, Melbourne, Australia; Royal Children's Hospital, Parkville, Victoria, Australia., Bonetto C; Italian Medicines Agency (AIFA), Rome, Italy., Buttery J; Monash Children's Hospital, Clayton, Melbourne, Australia; Murdoch Childrens Research Institute, Parkville, Victoria, Australia; Department of Paediatrics, Monash University, Clayton, Victoria, Australia., Pernus YB; The Brighton Collaboration Foundation, Basel, Switzerland., Chandler R; Uppsala Monitoring Centre, Uppsala, Sweden., Goldenthal KL; Independent Consultant, Bethesda, MD, USA., Kucuku M; Department of Vaccines Control, National Agency for Medicines and Medical Devices, Tirana, Albania., Monaco G; Pharmacovigilance Regional Centre of Lombardy, Italy., Pahud B; Children's Mercy Hospital, Kansas City, MO, USA., Shulman ST; Ann & Robert H. Lurie Children's Hospital of Chicago, USA., Top KA; Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada., Ulloa-Gutierrez R; Hospital Nacional de Niños 'Dr. Carlos Sáenz Herrera, San José, Costa Rica., Varricchio F; Independent Consultant Vaccinologist, Wakefield, RI, USA., de Ferranti S; Boston Children's Hospital, Boston, USA., Newburger JW; Boston Children's Hospital, Boston, USA., Dahdah N; CHU Sainte-Justine, Montreal, Canada., Singh S; Post Graduate Institute of Medical Education and Research (PGIMER) - Chandigarh, India., Bonhoeffer J; The Brighton Collaboration Foundation, Basel, Switzerland; University of Basel Children's Hospital, Basel, Switzerland. Electronic address: contact@brightoncollaboration.org., Burgner D; Monash Children's Hospital, Clayton, Melbourne, Australia; Murdoch Childrens Research Institute, Parkville, Victoria, Australia; Department of Paediatrics, Monash University, Clayton, Victoria, Australia; Department of Paediatrics, Melbourne University, Parkville, Victoria, Australia.
Publikováno v:
Vaccine [Vaccine] 2016 Dec 12; Vol. 34 (51), pp. 6582-6596. Date of Electronic Publication: 2016 Nov 15.
Autor:
Hersh AO; Department of Pediatrics Division of Rheumatology University of Utah, Salt Lake City, UT, USA. Electronic address: contact@brightoncollaboration.org., Alarcón GS; Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, AL, USA., Bonetto C; Italian Medicines Agency (AIFA), Rome, Italy., Pernus YB; Brighton Collaboration Foundation, Basel, Switzerland., Kucuku M; Department of Vaccines Control, National Agency of Medicines and Medical Devices, Tirana, Albania., Santuccio C; Italian Medicines Agency (AIFA), Rome, Italy., Živković S; University of Pittsburgh Medical Center, Pittsburgh, USA., Bonhoeffer J; Brighton Collaboration Foundation, Basel, Switzerland; University of Basel Children's Hospital, Basel, Switzerland.
Publikováno v:
Vaccine [Vaccine] 2016 Dec 12; Vol. 34 (51), pp. 6572-6581. Date of Electronic Publication: 2016 Nov 02.
Autor:
Imfeld P; Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland., Brauchli Pernus YB, Jick SS, Meier CR
Publikováno v:
Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2013; Vol. 35 (3), pp. 565-73.
Autor:
Derungs A; Abteilung für Klinische Pharmakologie und Toxikologie, Regionales Pharmacovigilance-Zentrum Basel, Universitätsspital Basel, Basel., Eberhardt K, Heiniger U, Rudin C, Brauchli Pernus YB
Publikováno v:
Praxis [Praxis (Bern 1994)] 2012 Jun 20; Vol. 101 (13), pp. 827-37; quiz 838.